You have no items in your shopping cart.
Docetaxel
Description
Images & Validation
−
Key Properties
−| CAS Number | 114977-28-5 |
|---|---|
| MW | 807.88 |
| Purity | 98.60% |
| Formula | C43H53NO14 |
| SMILES | O(C(C)=O)[C@]12[C@]3([C@H](OC(=O)C4=CC=CC=C4)[C@@]5(O)C(C)(C)C([C@@H](O)C(=O)[C@]3(C)[C@@H](O)C[C@]1(OC2)[H])=C(C)[C@@H](OC([C@@H]([C@@H](NC(OC(C)(C)C)=O)C6=CC=CC=C6)O)=O)C5)[H] |
| Target | Microtubule Associated,Apoptosis,Endogenous Metabolite |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Disclaimer | For research use only |
Similar Products
−
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
Documents Download
Request a Document
Protocol Information
Silvia Breusa a b , Eloise Thomas a , Noemi Baldinotti a , Serena Zilio a 1 , Jean-Guy Delcros c , Diana Marcela Hernandez-Palomino d , Weisha Qi e , Hanäé Guérin a , Benjamin Gibert b f , Patrick Mehlen b g , Ilaria Marigo d e , David Kryza a h , Giovanna Lollo Anti-Netrin-1 decorated nanoparticles combined with chemotherapy for the treatment of triple-negative breast cancer Biomaterials Advances, (2024)
Docetaxel (orb1309994)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review